NEW YORK (GenomeWeb) – The New York Genome Center said today that it has received conditional approval from the New York State Department of Health to offer a clinical constitutional whole-genome sequencing test.

The test will be run in NYGC's clinical laboratory, which is certified under New York State's Clinical Laboratory Evaluation Program (CLEP), and will use the center's Illumina's HiSeq X sequencing platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.